Shekhar Ghamande Selected Research

gimsilumab

1/2022

Anti-Granulocyte-Macrophage Colony-Stimulating Factor Monoclonal Antibody Gimsilumab for COVID-19 Pneumonia: A Randomized, Double-Blind, Placebo-controlled Trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Shekhar Ghamande Research Topics

Disease

14	COVID-19 06/2022 - 07/2021
5	Pneumonia (Pneumonitis) 01/2022 - 01/2017
4	Human Influenza (Influenza) 01/2022 - 01/2021
4	Hypoxia (Hypoxemia) 01/2022 - 01/2006
3	Infections 05/2022 - 09/2015
3	Respiratory Insufficiency (Respiratory Failure) 03/2022 - 08/2017
3	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 04/2020 - 08/2017
2	Critical Illness (Critically Ill) 01/2022 - 01/2020
1	Heart Arrest (Cardiac Arrest) 01/2022
1	Inflammation (Inflammations) 01/2022
1	Disease Progression 11/2021
1	False Aneurysm (Pseudoaneurysm) 03/2021
1	Invasive Pulmonary Aspergillosis 03/2021
1	Dementia (Dementias) 09/2020
1	Bacteremia 09/2020
1	Septic Shock (Toxic Shock Syndrome) 09/2020
1	Viral Pneumonia 10/2018
1	Virus Diseases (Viral Diseases) 10/2018
1	Fistula 01/2018
1	Cough 01/2018
1	Weight Loss (Weight Reduction) 01/2018
1	Diarrhea 01/2018
1	Empyema 01/2018
1	Colonic Pseudo-Obstruction (Ogilvie Syndrome) 08/2017
1	Rupture 08/2017
1	Ileus 08/2017
1	Lung Neoplasms (Lung Cancer) 09/2015
1	Heart Diseases (Heart Disease) 09/2015
1	Sleep Deprivation 01/2006
1	Apnea 01/2006
1	Sleep Apnea Syndromes (Sleep Apnea) 01/2006

Drug/Important Bio-Agent (IBA)

13	VaccinesIBA 06/2022 - 01/2021
10	mRNA VaccinesIBA 05/2022 - 07/2021
4	COVID-19 VaccinesIBA 06/2022 - 09/2021
3	BNT162 VaccineIBA 03/2022 - 11/2021
3	Messenger RNA (mRNA)IBA 02/2022 - 11/2021
2	2019-nCoV Vaccine mRNA-1273IBA 03/2022 - 01/2022
2	Influenza Vaccines (Influenza Vaccine)FDA Link 01/2022 - 01/2021
2	Anti-Bacterial Agents (Antibiotics)IBA 09/2020 - 01/2018
1	Monoclonal AntibodiesIBA 01/2022
1	gimsilumabIBA 01/2022
1	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 01/2022
1	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 01/2022
1	Immunoglobulin G (IgG)IBA 09/2021
1	galactomannanIBA 03/2021
1	Hemagglutinins (Hemagglutinin)IBA 01/2021
1	AntibodiesIBA 01/2021
1	Vancomycin FDA LinkGeneric 09/2020
1	AlbuminsIBA 09/2020
1	Crystalloid SolutionsIBA 01/2020
1	Azithromycin (Zithromax)FDA LinkGeneric 08/2019
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 10/2018
1	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 10/2018
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 10/2018
1	Ceftriaxone (Ceftriaxon)FDA LinkGeneric 01/2018
1	Tissue Plasminogen Activator (Alteplase)FDA Link 01/2018
1	Neostigmine (Neostigmine Bromide)IBA 08/2017
1	Polyethylene Glycols (Polyethylene Glycol)FDA LinkGeneric 08/2017
1	Lactulose (Duphalac)FDA LinkGeneric 08/2017
1	AntigensIBA 01/2017
1	Hypnotics and Sedatives (Sedatives)IBA 01/2006
1	Opioid Analgesics (Opioids)IBA 01/2006
1	Anesthetics (Anesthetic Agents)IBA 01/2006
1	Analgesics (Analgesic Drugs)IBA 01/2006

Therapy/Procedure

4	Therapeutics 01/2022 - 08/2017
2	Anesthesia 01/2022 - 01/2006
2	Positive-Pressure Respiration (Positive End-Expiratory Pressure) 01/2022 - 01/2020
2	Length of Stay 12/2021 - 09/2015
2	Noninvasive Ventilation 04/2020 - 01/2020
2	Induced Hypothermia 11/2017 - 08/2017
1	Critical Care (Surgical Intensive Care) 01/2022
1	Mechanical Ventilators (Ventilator) 12/2021
1	Artificial Respiration (Mechanical Ventilation) 11/2021
1	Highly Active Antiretroviral Therapy (HAART) 01/2018
1	Chest Tubes (Chest Tube) 01/2018
1	Thrombolytic Therapy 01/2018
1	Cecostomy 08/2017
1	Decompression 08/2017
1	Extracorporeal Membrane Oxygenation 08/2017